February 1, 2023
RegMed Investors’ (RMi) pre-open: the Fed will set the tone but, not the markets lyrics
January 31, 2023
RegMed Investors’ (RMi) pre-open: following the Fed as sector share pricing bounces
January 30, 2023
RegMed Investors’ (RMi) pre-open: Careful as you go … a week of uncertainty and pullbacks?
January 27, 2023
RegMed Investors’ (RMi) pre-open: wobble (stagger)or boggle (fear)?
January 26, 2023
RegMed Investors’ (RMi) pre-open: up, down, round and round goes the sector rope-tide to tan economic data driven market
January 25, 2023
RegMed Investors’ (RMi) pre-open: share pricing is all over the map as some gains reverse
January 24, 2023
RegMed Investors’ (RMi) pre-open: a wavering sector
January 23, 2023
RegMed Investors’ (RMi) pre-open: resistance versus resilience
January 20, 2023
RegMed Investors’ (RMi) pre-open: fear, the under-rated indicator or metric
January 19, 2023
RegMed Investors’ (RMi) pre-open: the path forward is bumpy and there is a headwind
January 18, 2023
RegMed Investors’ (RMi) pre-open: what do investors see – not far?
January 17, 2023
RegMed Investors’ (RMi) pre-open: sentiment is positioned on thin ice
January 13, 2023
RegMed Investors’ (RMi) pre-open: vulnerable?
January 12, 2023
RegMed Investors’ (RMi) pre-open: the cell/gene therapy sector reminds me of Abbott & Costello
January 11, 2023
RegMed Investors’ (RMi) pre-open: Day #3 of JPMorgan healthcare conference; All Quiet on the West Coast
January 10, 2023
RegMed Investors’ (RMi) pre-open: after a lackluster first day at JPM23 with smaller attendance, NO masks and a diving sector
January 9, 2023
RegMed Investors’ (RMi) pre-open: will JPM23 stimulate or just ripple share pricing?
January 6, 2023
RegMed Investors’ (RMi) pre-open: wait for it
January 5, 2023
RegMed Investors’ (RMi) pre-open: who says economics doesn’t affect the cell and gene therapy sector?
January 4, 2023
RegMed Investors’ (RMi) pre-open: a dash of strength
January 3, 2023
RegMed Investors’ (RMi) pre-open: Expectation will be the word for 2023
December 30, 2022
RegMed Investors’ (RMi) pre-open: end it on a positive note and good-bye to 2022 sessions
December 29, 2022
RegMed Investors’ (RMi) pre-open: risk-on/risk-off sessions based on market’s insecurity, sector’s pricing uncertainty in an overcrowded universe
December 28, 2022
RegMed Investors’ (RMi) pre-open: a holiday shortened week
December 27, 2022
RegMed Investors’ (RMi) pre-open: roaming and ranging, not today
6 hours 36 min ago
RMi Pre-opening: Shovel-out the portfolio
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors
© 2026 RegMed Investors (regmedinvestors.com), all rights are reserved.
RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.
The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.
The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.